Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Autonomous & Electric Vehicles (DRIV) vs Nuwellis Inc (NUWE) Price & Performance

Global X Autonomous & Electric VehiclesTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Global X Autonomous & Electric Vehicles vs Nuwellis Inc — how do they compare? Global X Autonomous & Electric Vehicles trades at $32.79 (market cap $356.37M), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: Global X Autonomous & Electric Vehicles is far larger — about 162× Nuwellis Inc's market cap, and Global X Autonomous & Electric Vehicles is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Autonomous & Electric Vehicles for 40 Days and Nuwellis Inc for 26 Days on average.

DRIVNUWE
Market Cap
$356.37M$2.20M
Volume
22,397121,544
Sector
Sector/ThematicHealth
52-Week High
$42.53$146.65
52-Week Low
$27.58$0.68
Typical Hold Time
40 Days26 Days
Enterprise Value
—-$1.52M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Autonomous & Electric Vehicles

DRIV trades at $32.60, down 2.29% today amid mixed technical signals with a bullish overall signal but bearish moving averages. The stock shows neutral momentum oscillators with RSI at 51.36 indicating balanced buying and selling pressure. Recent automotive sector news highlights hybrid vehicle momentum and China's ambitious EV targets, potentially benefiting automotive-focused ETFs.

The stock faces near-term resistance at $34 with technical indicators suggesting consolidation. Automotive sector transformation creates both opportunities from EV/hybrid adoption and risks from oil price volatility. Market sentiment remains divided as investors weigh technological shifts against traditional automotive challenges.

Nuwellis Inc

NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.

While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DRIV

No sentiment data available yet.

NUWE
2% Buy98% Sell
Avg holding period · 26 Days

Top news

Latest headlines on both assets

About Global X Autonomous & Electric Vehicles

DRIV invests in companies involved in autonomous driving and electric vehicle production. It tracks the Solactive Autonomous & Electric Vehicles Index, focusing on software and hardware leaders like Tesla, NVIDIA, and Microsoft.

Read more on DRIV →

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →